Physiological changes and clinical correlations of dyspnea in cancer outpatients

被引:61
作者
Dudgeon, DJ
Lertzman, M
Askew, GR
机构
[1] Queens Univ, Dept Med, Palliat Care Med Serv, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Internal Med, Kingston, ON K7L 3N6, Canada
[3] St Boniface Gen Hosp, Sect Resp Med, Winnipeg, MB R2H 2A6, Canada
[4] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada
[5] Univ Alberta, Dept Radiol, Edmonton, AB, Canada
关键词
dyspnea; etiology; cancer patients;
D O I
10.1016/S0885-3924(01)00278-0
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The purposes of this cross-sectional study of 75 outpatients of a general oncology clinic were to assess the subjective and objective factors associated with dyspnea in cancer patients and to characterize factors that might contribute to respiratory muscle weakness demonstrated in a previous study. Patients with moderate to severe shortness of breath completed visual analogue scales (VAS) of shortness of breath (SOB) and anxiety other data were acquired from pulmonary function tests, including maximum inspiratory pressure (MIP) and expiratory pressures; chest radiography; arterial blood gases; measurement of hemoglobin, serum potassium, phosphate, calcium, albumin, and magnesium; and ultrasound study of the diaphragm for thickness and excursion. The correlation coefficient between SOB VAS and a anxiety VAS was 0.26 (P = 0.03). In stepwise multiple regression analyses, only the regression coefficient for anxiety remained significant at P < 0.05 in the multivariate model with SOB VAS as the dependent variable. The multivariate model using MIP (a measure of respiratory muscle strength) as the dependent variable, Sound significance for total diaphragmatic excursion, hemoglobin, phosphate residual volume over total lung volume, vital capacity, percent predicted total lung capacity, oxygen saturation, and forced vital capacity. The regression coefficients for these variables were significant at P < 0.05 and the model accounted for 58% of the variance of MIP. (C) U.S. Cancer Pain Relief Committee, 2001.
引用
收藏
页码:373 / 379
页数:7
相关论文
共 19 条
[1]  
AHMEDZAI S, 1988, RESPIR DIS PRACT OCT, P20
[2]   EFFECT OF BODY-WEIGHT AND MUSCULARITY ON HUMAN DIAPHRAGM MUSCLE MASS, THICKNESS, AND AREA [J].
ARORA, NS ;
ROCHESTER, DF .
JOURNAL OF APPLIED PHYSIOLOGY, 1982, 52 (01) :64-70
[3]  
ARORA NS, 1982, AM REV RESPIR DIS, V126, P5
[4]   The frequency and correlates of dyspnea in patients with advanced cancer [J].
Bruera, E ;
Schmitz, B ;
Pither, J ;
Neumann, CM ;
Hanson, J .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2000, 19 (05) :357-362
[5]  
Cowcher K, 1990, J Pain Symptom Manage, V5, P320, DOI 10.1016/0885-3924(90)90048-O
[6]  
DUDGEON D, 1996, P AN M AM SOC CLIN, V15, P165
[7]   Management of dyspnea and cough in patients with cancer [J].
Dudgeon, DJ ;
Rosenthal, S .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (01) :157-+
[8]   Dyspnea in the advanced cancer patient [J].
Dudgeon, DJ ;
Lertzman, M .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1998, 16 (04) :212-219
[9]   The Edmonton Symptom Assessment Scale (ESAS) as an audit tool [J].
Dudgeon, DJ ;
Harlos, M ;
Clinch, JJ .
JOURNAL OF PALLIATIVE CARE, 1999, 15 (03) :14-19
[10]  
DUDGEON DJ, 1997, P AM SOC CLIN ONCOL, V16, P65